{
    "Participant": "hu342A08", 
    "Report URL": "http://evidence.personalgenomes.org/genomes?display_genome_id=54eeff493bbbf0a21691ff7ea5fd9e4ae7480152", 
    "Variants": [
        {
            "Allele Frequency": "0.0049", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "94517254", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "High", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "ABCA4", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 5, 
            "PMID List": [
                "9054934", 
                "10090887", 
                "11919200", 
                "11973624", 
                "18285826"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": "4", 
                "Functional": "0", 
                "Penetrance": "5", 
                "Severity": "4", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Various publications report this variant causes Stargardt Disease in a recessive manner, when combined with another more severe variant. Stargardt disease causes progressive vision loss and blindness.", 
            "URL": "http://evidence.pgp-hms.org/ABCA4-G863A", 
            "Variant Name": "ABCA4-G863A", 
            "Variant Page": "http://evidence.pgp-hms.org/ABCA4-G863A", 
            "dbSNP IDs": [
                "rs76157638"
            ]
        }, 
        {
            "Allele Frequency": "0.048", 
            "Build 37 Chromosome": "chr20", 
            "Build 37 Position": "61451332", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Muscular, skeletal, and connective tissue"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "COL9A3", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 1, 
            "PMID List": [
                "11308397"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Carriers of this collagen variant are associated with having a significantly increased risk of lumbar disc disease (~11% total risk compared to a typical risk of 4%). ", 
            "URL": "http://evidence.pgp-hms.org/COL9A3-R103W", 
            "Variant Name": "COL9A3-R103W", 
            "Variant Page": "http://evidence.pgp-hms.org/COL9A3-R103W", 
            "dbSNP IDs": [
                "rs61734651"
            ]
        }, 
        {
            "Allele Frequency": "0.0012", 
            "Build 37 Chromosome": "chr4", 
            "Build 37 Position": "6302799", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Mental and behavioral"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "WFS1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 2, 
            "PMID List": [
                "11244483", 
                "12955714"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported in a single case of familial depression, but no linkage data and no statistical significance.", 
            "URL": "http://evidence.pgp-hms.org/WFS1-C426Y", 
            "Variant Name": "WFS1-C426Y", 
            "Variant Page": "http://evidence.pgp-hms.org/WFS1-C426Y", 
            "dbSNP IDs": [
                "rs35218685"
            ]
        }, 
        {
            "Allele Frequency": "0.0053", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "117267812", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Breathing", 
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "CFTR", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "11186891", 
                "15987793"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "4", 
                "Severity": "3", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported to cause mild dysfunction of the cystic fibrosis gene, it may result in cystic fibrosis when combined with more severe variants.", 
            "URL": "http://evidence.pgp-hms.org/CFTR-S1235R", 
            "Variant Name": "CFTR-S1235R", 
            "Variant Page": "http://evidence.pgp-hms.org/CFTR-S1235R", 
            "dbSNP IDs": [
                "rs34911792"
            ]
        }, 
        {
            "Allele Frequency": "0.012", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "3304626", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "MEFV", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 5, 
            "PMID List": [
                "9668175", 
                "10090880", 
                "15458961", 
                "16439437", 
                "19820229"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "-1", 
                "Functional": null, 
                "Penetrance": "4", 
                "Severity": "3", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Some reports believe this cause Familial Mediterranean Fever in a recessive manner with reduced penetrance (i.e. not all get the disease). However, these reports lack strong statistical significance; other studies argue the variant is not associated with the disease.", 
            "URL": "http://evidence.pgp-hms.org/MEFV-E148Q", 
            "Variant Name": "MEFV-E148Q", 
            "Variant Page": "http://evidence.pgp-hms.org/MEFV-E148Q", 
            "dbSNP IDs": [
                "rs3743930"
            ]
        }, 
        {
            "Allele Frequency": "0.32", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "110818598", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Heart and circulatory"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "COL4A1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 3, 
            "PMID List": [
                "10334796", 
                "18077766", 
                "20031579"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.", 
            "URL": "http://evidence.pgp-hms.org/COL4A1-Q1334H", 
            "Variant Name": "COL4A1-Q1334H", 
            "Variant Page": "http://evidence.pgp-hms.org/COL4A1-Q1334H", 
            "dbSNP IDs": [
                "rs3742207"
            ]
        }, 
        {
            "Allele Frequency": "0.21", 
            "Build 37 Chromosome": "chr3", 
            "Build 37 Position": "148459988", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Drug response", 
                "Heart and circulatory"
            ], 
            "Evidence": "Likely", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "8021009", 
                "\n11250978", 
                "11593098", 
                "16046653", 
                "16675453", 
                "17668390"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": "2", 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.", 
            "URL": "http://evidence.pgp-hms.org/rs5186", 
            "Variant Name": "rs5186", 
            "Variant Page": "http://evidence.pgp-hms.org/rs5186", 
            "dbSNP IDs": [
                "rs5186"
            ]
        }, 
        {
            "Allele Frequency": "0.14", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TGIF1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 1, 
            "PMID List": [
                "10556296"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.", 
            "URL": "http://evidence.pgp-hms.org/TGIF1-P83Shift", 
            "Variant Name": "TGIF1-P83Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/TGIF1-P83Shift", 
            "dbSNP IDs": [
                "rs11571510"
            ]
        }, 
        {
            "Allele Frequency": "0.86", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "231050715", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SP110", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "16803959"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.", 
            "URL": "http://evidence.pgp-hms.org/SP110-L425S", 
            "Variant Name": "SP110-L425S", 
            "Variant Page": "http://evidence.pgp-hms.org/SP110-L425S", 
            "dbSNP IDs": [
                "rs3948464"
            ]
        }, 
        {
            "Allele Frequency": "0.63", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "7579472", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TP53", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "1975675", 
                "9607760", 
                "15355915", 
                "19837266", 
                "20615891", 
                "22184967"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.", 
            "URL": "http://evidence.pgp-hms.org/TP53-P72R", 
            "Variant Name": "TP53-P72R", 
            "Variant Page": "http://evidence.pgp-hms.org/TP53-P72R", 
            "dbSNP IDs": [
                "rs1042522"
            ]
        }, 
        {
            "Allele Frequency": "0.063", 
            "Build 37 Chromosome": "chr12", 
            "Build 37 Position": "10271087", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Genital and urinary", 
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "CLEC7A", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "19864674"
            ], 
            "Scores": {
                "Case/Control": null, 
                "Computational": "4", 
                "Familial": "1", 
                "Functional": "2", 
                "Penetrance": "4", 
                "Severity": "1", 
                "Treatability": "5"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant has been found to impair homan mucosal antifungal defense and was implicated in vulvovaginal candidiasis and mucocutaneous infections in a Dutch family.", 
            "URL": "http://evidence.pgp-hms.org/CLEC7A-Y238X", 
            "Variant Name": "CLEC7A-Y238X", 
            "Variant Page": "http://evidence.pgp-hms.org/CLEC7A-Y238X", 
            "dbSNP IDs": [
                "rs16910526"
            ]
        }, 
        {
            "Allele Frequency": "0.24", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "32906729", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "BRCA2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "11062481", 
                "15235023"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.", 
            "URL": "http://evidence.pgp-hms.org/BRCA2-N372H", 
            "Variant Name": "BRCA2-N372H", 
            "Variant Page": "http://evidence.pgp-hms.org/BRCA2-N372H", 
            "dbSNP IDs": [
                "rs144848"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": "-1", 
                "Penetrance": "0", 
                "Severity": "1", 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ", 
            "URL": "http://evidence.pgp-hms.org/rs1544410", 
            "Variant Name": "rs1544410", 
            "Variant Page": "http://evidence.pgp-hms.org/rs1544410", 
            "dbSNP IDs": [
                "rs1544410"
            ]
        }, 
        {
            "Allele Frequency": "0.22", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "16251599", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ABCC6", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "10811882", 
                "10913334", 
                "11776382", 
                "20038957"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "-1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "1", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.", 
            "URL": "http://evidence.pgp-hms.org/ABCC6-R1268Q", 
            "Variant Name": "ABCC6-R1268Q", 
            "Variant Page": "http://evidence.pgp-hms.org/ABCC6-R1268Q", 
            "dbSNP IDs": [
                "rs2238472"
            ]
        }, 
        {
            "Allele Frequency": "0.49", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "49206674", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Blood", 
                "Immune system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "FUT2", 
            "Impact": "Protective", 
            "Inheritance": "Recessive", 
            "PMID Count": 5, 
            "PMID List": [
                "7876235", 
                "12692541", 
                "19625485", 
                "20031047", 
                "22025362"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "5", 
                "Severity": "2", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are \"non-secretors\": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.", 
            "URL": "http://evidence.pgp-hms.org/FUT2-W154X", 
            "Variant Name": "FUT2-W154X", 
            "Variant Page": "http://evidence.pgp-hms.org/FUT2-W154X", 
            "dbSNP IDs": [
                "rs601338"
            ]
        }, 
        {
            "Allele Frequency": "0.34", 
            "Build 37 Chromosome": "chr20", 
            "Build 37 Position": "4680251", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "PRNP", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 2, 
            "PMID List": [
                "18236005", 
                "19081515"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "0", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.\n\n", 
            "URL": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "Variant Name": "PRNP-M129V", 
            "Variant Page": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "dbSNP IDs": [
                "rs1799990"
            ]
        }, 
        {
            "Allele Frequency": "0.048", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "CCR5", 
            "Impact": "Protective", 
            "Inheritance": "Recessive", 
            "PMID Count": 3, 
            "PMID List": [
                "8751444", 
                "8791590", 
                "8898752"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Also known as CCR5-delta32, this variant is associated with resistance to many strains of HIV (but not all strains, only strains that use target the CCR5 protein). Heterozygotes are reported to have slower HIV progression, and homozygotes are very resistant to being infected by these strains.", 
            "URL": "http://evidence.pgp-hms.org/CCR5-S185Shift", 
            "Variant Name": "CCR5-S185Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/CCR5-S185Shift", 
            "dbSNP IDs": [
                "rs333"
            ]
        }, 
        {
            "Allele Frequency": "0.047", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "202074098", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "CASP10", 
            "Impact": "Protective", 
            "Inheritance": "Dominant", 
            "PMID Count": 2, 
            "PMID List": [
                "10412980", 
                "16251207"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported to have a protective effect on breast cancer. If the lifetime risk of breast cancer is 12%, women with this variant may have a lower risk of 8-9% (30% less than average).", 
            "URL": "http://evidence.pgp-hms.org/CASP10-V410I", 
            "Variant Name": "CASP10-V410I", 
            "Variant Page": "http://evidence.pgp-hms.org/CASP10-V410I", 
            "dbSNP IDs": [
                "rs13010627"
            ]
        }, 
        {
            "Allele Frequency": "0.74", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "17409572", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "KCNJ11", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "17463246", 
                "17463248", 
                "20054294"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.", 
            "URL": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "Variant Name": "KCNJ11-K23E", 
            "Variant Page": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "dbSNP IDs": [
                "rs5219"
            ]
        }, 
        {
            "Allele Frequency": "0.1", 
            "Build 37 Chromosome": "chr9", 
            "Build 37 Position": "132580901", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "TOR1A", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "18519876", 
                "19380705", 
                "20669276"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "1", 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This SNP has been shown to be benign and play a protective role against Dystonia.  ", 
            "URL": "http://evidence.pgp-hms.org/TOR1A-D216H", 
            "Variant Name": "TOR1A-D216H", 
            "Variant Page": "http://evidence.pgp-hms.org/TOR1A-D216H", 
            "dbSNP IDs": [
                "rs1801968"
            ]
        }, 
        {
            "Allele Frequency": "0.068", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "44065090", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood", 
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "ABCG5", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19060911"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "2", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant has a mild protective effect on blood cholesterol. It is associated with slightly lower total and LDL cholesterol levels.", 
            "URL": "http://evidence.pgp-hms.org/ABCG5-R50C", 
            "Variant Name": "ABCG5-R50C", 
            "Variant Page": "http://evidence.pgp-hms.org/ABCG5-R50C", 
            "dbSNP IDs": [
                "rs6756629"
            ]
        }, 
        {
            "Allele Frequency": "0.26", 
            "Build 37 Chromosome": "chr15", 
            "Build 37 Position": "74219546", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "LOXL1", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 3, 
            "PMID List": [
                "17690259", 
                "18450598", 
                "20142848"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.", 
            "URL": "http://evidence.pgp-hms.org/LOXL1-R141L", 
            "Variant Name": "LOXL1-R141L", 
            "Variant Page": "http://evidence.pgp-hms.org/LOXL1-R141L", 
            "dbSNP IDs": [
                "rs1048661"
            ]
        }, 
        {
            "Allele Frequency": "0.023", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Heart and circulatory"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RNASEH2B", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "16845400"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is predicted to be highly disruptive. Although other disruptive variants in this gene are reported to cause Aicardi-Goutieres syndrome in a recessive manner (a rare, fatal childhood disease), those variants were upstream of this position, and this variant is too common to be consistent with causing that disease (2% allele frequency). Based on this, it is tentatively evaluated as benign.", 
            "URL": "http://evidence.pgp-hms.org/RNASEH2B-I309Shift", 
            "Variant Name": "RNASEH2B-I309Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/RNASEH2B-I309Shift"
        }, 
        {
            "Allele Frequency": "0.026", 
            "Build 37 Chromosome": "chr6", 
            "Build 37 Position": "132206079", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Heart and circulatory"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ENPP1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12881724", 
                "20137773"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": null, 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Tentatively classified as benign. Initially reported as a recessive cause of infantile arterial calcification, but with no statistical significance. Other variants have been implicated as causal in these cases this variant. 5% allele frequency in caucasians contradicts this variant as having any highly pathogenic effect.", 
            "URL": "http://evidence.pgp-hms.org/ENPP1-R774C", 
            "Variant Name": "ENPP1-R774C", 
            "Variant Page": "http://evidence.pgp-hms.org/ENPP1-R774C", 
            "dbSNP IDs": [
                "rs28933977"
            ]
        }, 
        {
            "Allele Frequency": "0.69", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "33951693", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SLC45A2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "15714523", 
                "17044855", 
                "18563784", 
                "18806926"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.", 
            "URL": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "Variant Name": "SLC45A2-L374F", 
            "Variant Page": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "dbSNP IDs": [
                "rs16891982"
            ]
        }, 
        {
            "Allele Frequency": "0.3", 
            "Build 37 Chromosome": "chr9", 
            "Build 37 Position": "98209594", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PTCH1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "15712338"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "Common polymorphism, presumed benign.", 
            "URL": "http://evidence.pgp-hms.org/PTCH1-P1315L", 
            "Variant Name": "PTCH1-P1315L", 
            "Variant Page": "http://evidence.pgp-hms.org/PTCH1-P1315L", 
            "dbSNP IDs": [
                "rs357564"
            ]
        }, 
        {
            "Allele Frequency": "0.16", 
            "Build 37 Chromosome": "chr10", 
            "Build 37 Position": "13340236", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PHYH", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "10767344", 
                "14974078"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. This variant was implicated as causing Refsum Disease in a recessive manner, but a subsequent publication noted that all instances were linked with other explanatory mutations. The high allele frequency of this variant in the population (7-13%) contradicts a pathogenic hypothesis.", 
            "URL": "http://evidence.pgp-hms.org/PHYH-P29S", 
            "Variant Name": "PHYH-P29S", 
            "Variant Page": "http://evidence.pgp-hms.org/PHYH-P29S", 
            "dbSNP IDs": [
                "rs28938169"
            ]
        }, 
        {
            "Allele Frequency": "0.89", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "55529187", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PCSK9", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19351729"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is likely benign. ", 
            "URL": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "Variant Name": "PCSK9-G670E", 
            "Variant Page": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "dbSNP IDs": [
                "rs505151"
            ]
        }, 
        {
            "Allele Frequency": "1.0", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "21235475", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "APOB", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "5", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This position is almost certainly an error in the HG18 reference sequence. ", 
            "URL": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "Variant Name": "APOB-Y1422C", 
            "Variant Page": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "dbSNP IDs": [
                "rs568413"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build 37 Chromosome": "chr8", 
            "Build 37 Position": "55539395", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RP1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12764676", 
                "19364639"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.", 
            "URL": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "Variant Name": "RP1-N985Y", 
            "Variant Page": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "dbSNP IDs": [
                "rs2293869"
            ]
        }, 
        {
            "Allele Frequency": "0.032", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "94512565", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ABCA4", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "9295268", 
                "11919200"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": "-1", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a polymorphism in a gene associated with Stargardt disease. Although it has a slight detectable effect in functional study, it is common in control groups and is not believed to have any significant pathogenic effect.", 
            "URL": "http://evidence.pgp-hms.org/ABCA4-R943Q", 
            "Variant Name": "ABCA4-R943Q", 
            "Variant Page": "http://evidence.pgp-hms.org/ABCA4-R943Q", 
            "dbSNP IDs": [
                "rs1801581"
            ]
        }, 
        {
            "Allele Frequency": "0.29", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "68855363", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TPCN2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "18488028"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Pigmentation allele.", 
            "URL": "http://evidence.pgp-hms.org/TPCN2-G734E", 
            "Variant Name": "TPCN2-G734E", 
            "Variant Page": "http://evidence.pgp-hms.org/TPCN2-G734E", 
            "dbSNP IDs": [
                "rs3829241"
            ]
        }, 
        {
            "Allele Frequency": "0.43", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "141673345", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TAS2R38", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "12595690", 
                "15883422", 
                "20675712"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "5", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is strongly associated with causing the \"taster\" phenotype of phenylthiocarbamine (PTC) in a dominant manner.", 
            "URL": "http://evidence.pgp-hms.org/TAS2R38-A49P", 
            "Variant Name": "TAS2R38-A49P", 
            "Variant Page": "http://evidence.pgp-hms.org/TAS2R38-A49P", 
            "dbSNP IDs": [
                "rs713598"
            ]
        }, 
        {
            "Allele Frequency": "0.46", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "141672604", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TAS2R38", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12595690", 
                "20675712"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with \"taster\" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.", 
            "URL": "http://evidence.pgp-hms.org/TAS2R38-I296V", 
            "Variant Name": "TAS2R38-I296V", 
            "Variant Page": "http://evidence.pgp-hms.org/TAS2R38-I296V", 
            "dbSNP IDs": [
                "rs10246939"
            ]
        }, 
        {
            "Allele Frequency": "0.27", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "88911696", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TYR", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "17952075", 
                "17999355"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).", 
            "URL": "http://evidence.pgp-hms.org/TYR-S192Y", 
            "Variant Name": "TYR-S192Y", 
            "Variant Page": "http://evidence.pgp-hms.org/TYR-S192Y", 
            "dbSNP IDs": [
                "rs1042602"
            ]
        }
    ]
}